Código QR (código de barras bidimensional)

Effectiveness of sorafenib in treating intermediate-stage hepatocellular carcinoma patients refractory to transarterial chemoembolization

Abstract Background Switching to systemic therapy after transarterial chemoembolization (TACE) refractoriness is more inclined to preserve liver function and decrease disease progression. Hence, we conducted a comparison between the advantages of sorafenib therapy and the continuation of TACE in pat...

ver descrição completa

Na minha lista:
Principais autores: Reham Ashour, Eman Rewisha, Mohamed AKL Rady, Sally Waheed Elkhadry, Heba Abdelhalim, Mohamed Atef
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2024-11-01
coleção:BMC Cancer
Assuntos:
Hepatocellular carcinoma
Sorafenib
Transarterial chemoembolization
Refractorness
Intermediate-stage patients
Acesso em linha:https://doi.org/10.1186/s12885-024-13199-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados